EV/EBITDA
-49.76
+1.93+3.73%
Fri, 07 Feb 2025 21:01:27 GMT
Summary
- As of February 7, 2025, RAPP EV/EBITDA is -49.76, with a rise of +1.93 (+3.73%) during the most recent trading day.
- RAPP EV/EBITDA is now -32.66% below its all-time high of -37.51.
Performance
RAPP EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RAPP EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +3.7% | -3.7% | -3.7% |
| 1 m1 month | +9.4% | -9.4% | -9.3% |
| 3 m3 months | +40.3% | -40.3% | -40.0% |
| 6 m6 months | +27.4% | -13.2% | -14.5% |
| ytdytd | +9.2% | -9.2% | -9.1% |
| 1 y1 year | - | - | - |
| 5 y5 years | - | - | - |
RAPP EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -32.7% | -56.83 | +12.4% | |
| 3 m | 3-month | -37.51 | -32.7% | -83.33 | +40.3% |
| 6 m | 6-month | -37.51 | -32.7% | -90.59 | +45.1% |
| 1 y | 1-year | -37.51 | -32.7% | -125.55 | +60.4% |
| 3 y | 3-year | -37.51 | -32.7% | -125.55 | +60.4% |
| 5 y | 5-year | -37.51 | -32.7% | -125.55 | +60.4% |
| alltime | all time | -37.51 | -32.7% | -125.55 | +60.4% |
Rapport Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -49.76(-9.1%) |
| Date | Value |
|---|---|
| 2024 | -54.77 |
FAQ
- What is Rapport Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Rapport Therapeutics?
- What is RAPP EV/EBITDA year-to-date change?
What is Rapport Therapeutics EV/EBITDA?
The current EV/EBITDA of RAPP is -49.76
What is the all time high EV/EBITDA for Rapport Therapeutics?
Rapport Therapeutics all-time high EV/EBITDA is -37.51
What is RAPP EV/EBITDA year-to-date change?
Rapport Therapeutics EV/EBITDA has changed by +5.01 (+9.15%) since the beginning of the year